CROSS COUNTRY HEALTHCARE INC(CCRN)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Rank #2,194 of 2,879 stocks
Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Aug 14, 2026.
Revenue Growth
Profitability
Balance Sheet
Earnings Quality
Free Cash Flow
Institutional Flow
Revenue Scale
Dilution Risk
CCRN Stock Analysis & AI Quality Score
AI stock analysis and institutional research for CROSS COUNTRY HEALTHCARE INC (CCRN), a Industrials sector company. 13F Pro's AI-powered ranking engine scores CCRN at 34.5/100 on a 32-signal composite quality model, placing it at rank #2,194 of 2,879 stocks — the bottom half of the AI-ranked universe. CCRN scores in the top quartile across institutional flow (90.1). Areas of concern include revenue growth (4.7) and balance sheet strength (26.3), which score below median versus the broader universe. Based on the latest XBRL financial filings (Q1 2026), CROSS COUNTRY HEALTHCARE INC reports quarterly revenue of $241.1M, net income of $-4.3M, free cash flow of $3.3M. Top institutional holders of CCRN by reported 13-F value include Boston Partners, BlackRock,, DIMENSIONAL FUND ADVISORS, based on the most recent SEC filings. CCRN trades on the Nasdaq exchange and files with the SEC under CIK 1141103. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate CCRN daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for CROSS COUNTRY HEALTHCARE INC directly from SEC EDGAR. CROSS COUNTRY HEALTHCARE INC's 13F Pro composite quality score has ranged between 29 and 70 since 2021, currently 34.5 — a declining long-term trajectory across 28 quarterly and live scoring snapshots.
Revenue
Q1 2026
$241.1M
Net Income
Q1 2026
$-4.3M
Free Cash Flow
Q1 2026
$3.3M
Revenue & Net Income
Earnings Per Share
Key Financials Over Time
Export Financial Table · Pro+Revenue
-21.6% YoYNet Income
-551.6% YoYOperating Income
-400.5% YoYEPS (Diluted)
-565.9% YoYTotal Assets
-23.8% YoYTotal Debt
Op. Cash Flow
-59.8% YoY| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $1.05B -21.6% | $1.34B -33.5% | $2.02B -28.0% | $2.80B +67.2% | $1.68B +100.5% | $836.4M |
| Net Income | $-94.9M -551.6% | $-14.6M -120.0% | $72.6M -60.9% | $186.0M +40.9% | $132.0M +1118.4% | $-13.0M |
| Operating Income | $-84.4M -400.5% | $-16.9M -115.0% | $112.7M -58.2% | $269.9M +93.7% | $139.3M +1620.8% | $-9.2M |
| EPS (Diluted) | $-2.93 -565.9% | $-0.44 -121.5% | $2.05 -58.6% | $4.95 +40.2% | $3.53 +1080.6% | $-0.36 |
| Total Assets | $449.0M -23.8% | $589.3M -13.5% | $681.1M -28.3% | $949.6M +29.6% | $732.8M +105.3% | $357.0M |
| Total Debt | — | — | — | $150.7M -19.0% | $185.9M +219.2% | $58.3M |
| Operating Cash Flow | $48.3M -59.8% | $120.1M -51.7% | $248.5M +85.4% | $134.1M +256.6% | $-85.6M -414.7% | $27.2M |
AI Insight: CCRN Financial Trends
Revenue has declined 29% from Q2 2024 to Q1 2026, with Q4 2025 delivering a catastrophic $83M net loss that erased $96M of equity.
• Revenue fell from $340M in Q2 2024 to $241M in Q1 2026, an eight-quarter uninterrupted contraction of nearly 29%.
• Operating income has been negative in 7 of 8 quarters, worsening sharply to -$72M in Q4 2025 from -$6M in Q2 2025.
• Equity eroded from $433M in Q2 2024 to $313M in Q1 2026, a $120M decline driven largely by the Q4 2025 net loss.
• Operating cash flow turned positive at $18M in Q4 2025 and $5M in Q1 2026 despite deep net losses, offering a faint offset.
⚠ Q4 2025's $83M net loss — far exceeding any prior quarter — warrants scrutiny for impairment charges or one-time write-downs.
⚠ Equity has dropped to $313M in Q1 2026; continued losses risk further balance sheet deterioration with no debt data visible.
⚠ Revenue stabilized slightly to $241M in Q1 2026 from $237M in Q4 2025 — watch whether this marks a bottom or a pause.
AI Insight: CCRN Ratio Trends
A massive Q4 2025 write-down (-30.2% OpMargin, -102.8% ROE) masks a modest Q1 2026 stabilization, but CCRN has not posted a positive operating margin since Q3 2024.
• Operating margin turned negative after Q3 2024's 0.9% peak, deteriorating to -30.2% in Q4 2025 before partially recovering to -1.7% in Q1 2026.
• ROE collapsed to -102.8% in Q4 2025 from -0.5% in Q1 2025, reflecting a severe one-off charge that quarter.
• Q1 2026 shows sequential improvement: OpMargin recovered to -1.7% and ROE to -5.5% from Q4 2025's extreme lows.
⚠ TTM OpMargin of -8.7% and ROE of -31.5% remain deeply negative — sustained profitability recovery is not yet visible in trailing figures.
⚠ Monitor whether Q4 2025's charge was truly one-off; recurrence would extend the unbroken streak of quarterly operating losses.
⚠ D/E data is absent across all periods — leverage position is unquantifiable, adding balance-sheet uncertainty.
Get alerted when CCRN's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for CROSS COUNTRY HEALTHCARE INC including:
Top Institutional Holders of CCRN
Boston Partners
$23.9M2,545,584 shBlackRock, Inc.
$23.6M2,507,042 shDIMENSIONAL FUND ADVISORS LP
$15.1M1,609,925 shVANGUARD CAPITAL MANAGEMENT LLC
$12.9M1,369,654 shSio Capital Management, LLC
$10.3M1,098,393 shQuinn Opportunity Partners LLC
$9.6M1,025,620 shCHARLES SCHWAB INVESTMENT MANAGEMENT INC
$8.9M952,125 shAMERICAN CENTURY COMPANIES INC
$8.9M948,128 shODDO BHF ASSET MANAGEMENT SAS
$8.8M940,000 shDana Investment Advisors, Inc.
$8.8M933,217 sh
| Fund | Value | Shares |
|---|---|---|
| Boston Partners | $23.9M | 2,545,584 |
| BlackRock, Inc. | $23.6M | 2,507,042 |
| DIMENSIONAL FUND ADVISORS LP | $15.1M | 1,609,925 |
| VANGUARD CAPITAL MANAGEMENT LLC | $12.9M | 1,369,654 |
| Sio Capital Management, LLC | $10.3M | 1,098,393 |
| Quinn Opportunity Partners LLC | $9.6M | 1,025,620 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $8.9M | 952,125 |
| AMERICAN CENTURY COMPANIES INC | $8.9M | 948,128 |
| ODDO BHF ASSET MANAGEMENT SAS | $8.8M | 940,000 |
| Dana Investment Advisors, Inc. | $8.8M | 933,217 |
More Industrials Companies
View all Industrials →Put CCRN on your watchlist
Track score changes the day CROSS COUNTRY HEALTHCARE INC files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is CCRN a good stock to buy?
13F Pro's AI-powered analysis of CROSS COUNTRY HEALTHCARE INC (CCRN) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Industrials sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for CCRN are available on the CCRN stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.
Which hedge funds own CCRN?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling CCRN. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of CROSS COUNTRY HEALTHCARE INC's investment landscape.